FilingReader Intelligence

BeOne Medicines to release Q3 2025 financial results November 6

October 22, 2025 at 10:21 AM UTCBy FilingReader AI

BeOne Medicines Ltd. will release its unaudited financial results for the third quarter ended September 30, 2025, on Thursday, November 6, 2025. These results, prepared in accordance with U.S. Generally Accepted Accounting Principles, will be announced after trading hours of the Hong Kong Stock Exchange. The company’s audit committee is scheduled to review and approve these results on the same date.

Following the announcement, BeOne Medicines will host a conference call with its management at 8:00 a.m. U.S. Eastern Time (9:00 p.m. Hong Kong Time) on Thursday, November 6, 2025. The conference call will be webcast live and accessible via multiple links on the company’s investor relations websites, with an archived version also available. Participants are advised to register at least 15 minutes prior to the scheduled webcast.

The board of directors, as of October 22, 2025, includes John V. Oyler as chairman and executive director, Dr. Xiaodong Wang as non-executive director, and a diverse group of independent non-executive directors.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

HKEX:6160Hong Kong Exchange

News Alerts

Get instant email alerts when BeiGene publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →